Latest Manufacturing News

Zimi Limited confirms $1.42 million in open orders with key distributor GSM Electrical, backed by shareholder approval for up to $6 million in future sales. The company also advances its commercial market ambitions through a new partnership with Zencontrol.

CL8 Holdings Limited reported strong subscriber growth and revenue gains in the March 2025 quarter, while preparing to sell its operating entities to streamline costs and improve cash flow.

Cardiex reports strong early sales momentum for its CONNEQT Pulse device with approximately 3,000 units sold or contracted since its mid-January launch, supported by innovative app features and operational efficiencies. Despite regulatory delays in the US pharma sector and tariff challenges, the company is positioned for scalable growth and category leadership in preventative cardiovascular care.

Cardiex Limited reported a $2.06 million cash outflow for Q3 2025 but is driving cost savings and new revenue streams while planning a capital raise to reach positive cash flow.

BluGlass Limited has achieved a world-record 1250mW single-mode GaN laser chip and strengthened its commercial pipeline with a $120,000 repeat order, positioning itself for rapid growth in photonics markets.

Investor Centre Limited is advancing key capital raising negotiations while its subsidiary Pulse Markets grows its wholesale trading business, positioning the company for operational expansion in 2025.

Lithium Universe Limited has delivered a robust Definitive Feasibility Study for its Bécancour Lithium Carbonate Refinery, confirming strong economic viability and progressing toward project funding and strategic collaborations.

Harvest Technology Group reported a 19% improvement in normalized EBITDA for Q3 FY25 alongside a $1.6 million capital raise, reinforcing its strategic plan to achieve profitability by FY27.

TZ Limited reported a challenging Q3 FY2025 with a $1.03 million net cash outflow amid US tariff disruptions but strengthened its SaaS base through the Keyvision acquisition, positioning for a rebound and growth in FY2026.

Anatara Lifesciences reports mixed results from its Phase II GaRP-IBS trial, missing the primary efficacy target but showing significant improvements in anxiety and patient-reported relief, while advancing its anti-obesity pre-clinical program.

Eden Innovations reports robust growth in EdenCrete®Pz7 sales, driven by expanded orders from Holcim Ecuador and the USA, alongside strategic US property sales aimed at debt reduction and operational efficiency.

Terragen Holdings has launched its new probiotic products for ruminants, initiated multiple key trials including methane mitigation and crop yield studies, and secured a US patent allowance, positioning itself for global market expansion.